September 3rd 2021
The first and only treatment to use proprietary precision olfactory delivery technology to deliver DHE to the upper nasal cavity just received FDA approval.
September 3rd 2021
A hypnotic might be a good option for augmenting depression treatment, but which hypnotic has the best evidence for efficacy?
September 3rd 2021
"I want a god as my accomplice..."
September 3rd 2021
In this new series, you will find reflections on psychiatry and society as seen in—and inspired by—current events.
September 3rd 2021
Are benzodiazepine prescriptions contributing to the opioid overdose epidemic?
September 03, 2021
6 frontline physician groups expressed their concern about the Texas state law that bans abortions after 6 weeks of pregnancy.
September 02, 2021
The summer began with such promise. Where did it go? And what hope can we see in the future?
September 02, 2021
Our roundup of free CMEs features innovating strategies for diagnosing and addressing the neuropsychiatric signs of multiple sclerosis, the therapeutic potential of psilocybin, poststroke depression, and more.
September 02, 2021
After a string of disappointing results, mirtazapine gets another look in a recent study.
September 02, 2021
The newest law in Texas dictating women's health brings with it many issues for consideration.
September 01, 2021
What's the risk?
September 01, 2021
The one-of-its-kind 6-month paliperidone palmitate treatment for schizophrenia has received FDA approval.
August 31, 2021
What are some ways to overcome anxieties about returning to "normal"?